Reuters: "WASHINGTON (Reuters) - An antibiotic pill originally developed to help prevent rejection in organ transplant patients helps mice live longer and might offer a route to fighting age-related disease in people, U.S. researchers reported on Monday.
The drug, called rapamycin or sirolimus and marketed under the brand name Rapamune by Wyeth, suppresses the immune system but also fights inflammation, which underlies cancer, heart disease, Alzheimer's disease and a range of other ills."
Saturday, July 11, 2009
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment